Terry Yanofsky and David Lazzarato appointed as John Bell and Peter
Stringham retire from the CGC Board.
SMITHS FALLS, ON, April 1, 2020 /PRNewswire/ - Canopy Growth
Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE:
CGC) is pleased to announce that Ms.Terry
Yanofsky and Mr. David
Lazzarato have been appointed to the Company's Board of
Directors, effective immediately.
"It is my pleasure to welcome both Terry and David to the
board," said Judy Schmeling, Chair
of the Board of Directors, Canopy Growth. "Their leadership and
experience in highly competitive industries will be instrumental as
we focus the business and evolve into an execution-driven operating
company. I also want to thank outgoing board members, Peter Stringham and John
Bell, for their contribution and service to the board during
times of rapid expansion and growth."
John Bell is the former Lead
Director and Peter Stringham Chaired the Corporate Governance,
Compensation and Nominating Committee.
Ms. Yanofsky has extensive experience working with big-name
retailers and is respected for her strategic leadership and
disciplined approach to driving revenue. She most recently served
as the Senior Vice-President, General Manager of Sephora Canada. Prior to joining Sephora, Ms.
Yanofsky worked at L Brands where she was the country manager for
Bath & Body Works Canada. She brings over 30 years of
experience working with rapidly growing big-name global
retailers.
"I'm thrilled to join Canopy's Board" said Ms. Yanofsky. "There
is no company better positioned in the emerging global cannabis
market, and I look forward to working with Canopy Growth's very
talented leadership team to ensure that it remains an innovator and
disruptor in the cannabis retail market."
Mr. Lazzarato's impressive career includes senior executive
positions with Alliance Atlantis Communications, Allstream,
Bell Canada and CAE. He also
has extensive board experience and currently serves as The Star
Group's Chairman of the Audit Committee and as a member of the
Corporate Governance and Nominating Committee. Mr. Lazzarato brings
to the board a demonstrated commercial and financial acumen to
assist businesses going through pivotal inflection points.
"I'm honoured to be a member of the Board of Directors at Canopy
Growth," Mr. Lazzarato said. "I look forward to working with my
fellow board members and the entire Canopy Growth leadership team
to build on the foundation that has been laid as we expand and
transform the company to maintain its position as leader in the
cannabis industry."
Ms. Yanofsky's and Mr. Lazzarato's full bios are available at
www.canopygrowth.com.
About Canopy Growth Corporation
Canopy Growth
(TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp
and cannabis device company, offering distinct brands and curated
cannabis varieties in dried, oil and Softgel capsule forms, as well
as medical devices through Canopy Growth's subsidiary, Storz &
Bickel GMbH & Co. KG. From product and process innovation to
market execution, Canopy Growth is driven by a passion for
leadership and a commitment to building a world-class cannabis
company one product, site and country at a time. Canopy Growth has
operations in over a dozen countries across five continents.
Canopy Growth's medical division, Spectrum Therapeutics is
proudly dedicated to educating healthcare practitioners, conducting
robust clinical research, and furthering the public's understanding
of cannabis, and has devoted millions of dollars toward cutting
edge, commercializable research and IP development. Spectrum
Therapeutics sells a range of full-spectrum products using its
colour-coded classification Spectrum system as well as single
cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its
award-winning Tweed and Tokyo Smoke banners. Tweed is a globally
recognized cannabis brand which has built a large and loyal
following by focusing on quality products and meaningful customer
relationships.
From our historic public listing on the Toronto Stock Exchange
and New York Stock Exchange to our continued international
expansion, pride in advancing shareholder value through leadership
is engrained in all we do at Canopy Growth. Canopy Growth has
established partnerships with leading sector names including
cannabis icons Snoop Dogg and Seth
Rogen, breeding legends DNA Genetics and Green House Seeds,
and Fortune 500 alcohol leader Constellation Brands, to name but a
few. Canopy Growth operates eleven licensed cannabis production
sites with over 10.5 million square feet of production capacity,
including over one million square feet of GMP certified production
space. For more information visit www.canopygrowth.com
Notice Regarding Forward Looking Statements
This news
release contains "forward-looking statements" within the meaning of
the United States Private Securities Litigation Reform Act of 1995
and "forward-looking information" within the meaning of applicable
Canadian securities legislation. Often, but not always,
forward-looking statements and information can be identified by the
use of words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements or information involve known and unknown
risks, uncertainties and other factors which may cause the actual
results, performance or achievements of Canopy Growth or its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements or information contained in this news
release. Risks, uncertainties and other factors involved with
forward-looking information could cause actual events, results,
performance, prospects and opportunities to differ materially from
those expressed or implied by such forward-looking information,
including the Company's ability to satisfy provincial sales
contracts or provinces purchasing all cannabis allocated to them,
and such risks contained in the Company's annual information form
dated June 25, 2019 and filed with
Canadian securities regulators available on the Company's issuer
profile on SEDAR at www.sedar.com. Although the Company believes
that the assumptions and factors used in preparing the
forward-looking information or forward-looking statements in this
news release are reasonable, undue reliance should not be placed on
such information and no assurance can be given that such events
will occur in the disclosed time frames or at all. The
forward-looking information and forward-looking statements included
in this news release are made as of the date of this news release
and the Company does not undertake an obligation to publicly update
such forward-looking information or forward-looking information to
reflect new information, subsequent events or otherwise unless
required by applicable securities laws.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/canopy-growth-announces-changes-to-its-board-of-directors-301033186.html
SOURCE Canopy Growth Corporation